Differences in classification schemata for myelodysplastic/myeloproliferative overlap neoplasms
Leukemia
.
2022 Dec;36(12):2934-2938.
doi: 10.1038/s41375-022-01754-3.
Epub 2022 Nov 5.
Authors
Mrinal M Patnaik
1
,
Amer M Zeidan
2
,
Eric Padron
3
,
Uwe Platzbecker
4
,
David A Sallman
3
,
Amy E DeZern
5
,
Rafael Bejar
6
,
Mikkael Sekeres
7
,
Justin Taylor
7
,
Richard F Little
8
,
Jan P Bewersdorf
9
,
Tae Kon Kim
10
,
Nina Kim
8
,
Christopher S Hourigan
8
,
Matteo G Dela Porta
11
,
Maximilian Stahl
12
,
David Steensma
13
,
Mina L Xu
14
,
Olatoyosi Odenike
15
,
Hetty Carraway
16
,
Pierre Fenaux
17
,
Aziz Nazha
18
,
Rami Komrokji
3
,
Sanam Loghavi
19
,
Zhuoer Xie
3
,
Robert Hasserjian
20
,
Michael Savona
10
,
John M Bennett
21
Affiliations
1
Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
[email protected]
.
2
Section of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA.
3
Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA.
4
Department of Hematology, University of Leipzig, Leipzig, Germany.
5
Division of Hematologic Malignancies; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.
6
Division of Hematology and Oncology, Moores Cancer Center, UC San Diego, La Jolla, CA, USA.
7
Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
8
National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
9
Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
10
Division of Hematology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
11
Humanitas Clinical and Research Center & Humanitas University, Department of Biomedical Sciences, Milan, Italy.
12
Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
13
Novartis Institute of Blood Research, Boston, MA, USA.
14
Departments of Pathology & Laboratory Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA.
15
Section of Hematology/Oncology, the University of Chicago Medicine, Chicago, IL, USA.
16
Leukemia Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
17
Hôpital St Louis, Assistance Publique Hôpitaux de Paris, and Université Paris Cité, Paris, France.
18
Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
19
Department of Hematopathology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
20
Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
21
Department of Medicine, Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA.
PMID:
36335264
DOI:
10.1038/s41375-022-01754-3
No abstract available
Publication types
Letter
MeSH terms
Humans
Myelodysplastic-Myeloproliferative Diseases* / genetics
Myeloproliferative Disorders* / genetics
Neoplasms*